PCM1-JAK2 Fusion Product Selectively Activates MAP-Kinase Pathway and Fails to Phosphorylate JAK2 and STAT5: Implications for Therapeutic Strategies / Masselli, E; Mecucci, C; Gobbi, G; Carubbi, C; Bonomini, S; Prezioso, L; Rossetti, E; Caramatti, C; Vitale, M; Aversa, F.. - In: BLOOD. - ISSN 0006-4971. - 120:21(2012), pp. 2858-2858. (Intervento presentato al convegno 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)).
PCM1-JAK2 Fusion Product Selectively Activates MAP-Kinase Pathway and Fails to Phosphorylate JAK2 and STAT5: Implications for Therapeutic Strategies.
Masselli, E;Gobbi, G;Carubbi, C;Prezioso, L;Caramatti, C;Vitale, M;Aversa, F.
2012-01-01
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
